Why the study?
Does sodium citrate as the sole anticoagulant prevent clotting and reduce bleeding complications in hemodialysis patients at high risk for hemorrhage?
Population
Hemodialysis patients at high risk for hemorrhage
Design
Other
Authors
Loading...
May enable citrate anticoagulation in high-bleeding-risk hemodialysis; leaves open prospective validation before practice change.
Does sodium citrate as the sole anticoagulant prevent clotting and reduce bleeding complications in hemodialysis patients at high risk for hemorrhage?
The authors developed a unique method using sodium citrate as the sole anticoagulant for hemodialysis in patients at high risk for bleeding.
Pinnick et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: